Lim Lee-Moay, Kuo Hung-Tien, Chao Yu-Lin, Shen Feng-Ching, Chen Yi-Kong, Chiu Yi-Wen, Hwang Shang-Jyh, Hung Chi-Chih
Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.
School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.
Nutrients. 2024 Nov 23;16(23):4014. doi: 10.3390/nu16234014.
The malnutrition-inflammation score (MIS) is a practical and accessible tool for evaluating protein energy wasting (PEW) in patients on dialysis. However, the severity of PEW at each stage of chronic kidney disease (CKD), especially with late dialysis initiation, is unclear. We evaluated the MIS of 3659 patients with CKD stages 1-5 and the changes in their MIS results at baseline and at the time before dialysis initiation. Patients were defined to have PEW if they had a subjective global assessment (SGA) rating of C or lower. The MIS increased substantially over a follow-up period of 6.12 years for 1124 patients just starting dialysis, with 49.3% having an MIS of 8. The pre-dialysis MIS was associated with baseline MIS, age, cardiovascular disease, and cancer. The prevalence of PEW based on an SGA rating of C or lower increased from 10.5% at baseline to 61.2% immediately before dialysis. The prevalence of PEW based on an MIS of ≥8 increased from 28.5% at baseline to 49.3% immediately before dialysis. In CKD stage 5 patients, 29.4% had PEW based on an MIS of 8 or less, and 11.6% had an SGA rating of C. The MIS was revealed to be associated with renal function, nutritional markers, and cardiometabolic disease (diabetes or cardiovascular disease). In conclusion, the MIS increased as CKD progressed to stages 4 and 5, as well as just prior to dialysis. Our study identified patients who required PEW assessment on the basis of their MIS results.
营养不良-炎症评分(MIS)是评估透析患者蛋白质能量消耗(PEW)的一种实用且可获取的工具。然而,慢性肾脏病(CKD)各阶段PEW的严重程度,尤其是在透析起始较晚的情况下,尚不清楚。我们评估了3659例CKD 1-5期患者的MIS以及他们在基线和透析起始前的MIS结果变化。如果患者的主观全面评定(SGA)等级为C或更低,则定义为患有PEW。在6.12年的随访期内,1124例刚开始透析的患者的MIS大幅增加,其中49.3%的患者MIS为8。透析前的MIS与基线MIS、年龄、心血管疾病和癌症相关。基于SGA等级为C或更低的PEW患病率从基线时的10.5%增加到透析前即刻的61.2%。基于MIS≥8的PEW患病率从基线时的28.5%增加到透析前即刻的49.3%。在CKD 5期患者中,29.4%的患者基于MIS为8或更低患有PEW,11.6%的患者SGA等级为C。研究发现MIS与肾功能、营养指标和心脏代谢疾病(糖尿病或心血管疾病)相关。总之,随着CKD进展到4期和5期以及透析前,MIS升高。我们的研究根据MIS结果确定了需要进行PEW评估的患者。